Press Releases

Mednow to Host Q2/22 Conference Call on Wednesday March 23, 2022, at 8:30am EST on Financial Results and Corporate Update

Toronto, ON. (March 15, 2022) – Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Wednesday March 23, 2022 at 8:30am EST. The conference call will cover its second-quarter 2022 financial results, and a corporate update.  

During the call, the Mednow team will provide an update on Mednow’s expansion, recent strategic partnerships, milestones, M&A activities, and second-quarter 2022 financial results. Please use one of the two dial-in numbers provided below five minutes before the scheduled start time and specify the Mednow call. 

Conference Call details:

Canada/USA Toll-free: 1-800-319-4610

International Toll: 1-604-638-5340

The conference call will be available on our website at: for playback within one business days.

About Mednow Inc.

Mednow is a healthcare technology company offering virtual access with a high-standard of care. Designed with accessibility and quality of care in mind, provides virtual pharmacy and telemedicine services as well as doctor home visits through an interdisciplinary approach to healthcare that is focused on the patient experience. Mednow’s services include free at-home delivery of medications, a user-friendly interface for easy upload, transfer, and refill of prescriptions, access to healthcare professionals through an intuitive chat experience, a specialized PillSmart™ system that packages prescriptions and vitamins by date and time, and doctor consultations.

To learn more, follow Mednow on Facebook, Twitter, LinkedIn, and Instagram, or visit our website at

Investor Relations Contact: 

Benjamin Ferdinand, Chief Financial Officer

Lucy Chitilian, CFA, Head of Investor Relations


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.